{"title":"Advances in Wound Healing Strategies for Diabetic Foot Ulcers: From Conventional to Regenerative Therapies.","authors":"Abdullah Alwahbi","doi":"10.2174/0115733998407601251010114114","DOIUrl":null,"url":null,"abstract":"<p><p>Diabetic Foot Ulcer (DFU) is a serious and chronic complication of uncontrolled diabetes, significantly increasing the risk of amputation and mortality in diabetic patients. Conventional wound healing techniques often fail to manage chronic wounds in DFU due to several limitations, which eventually raises the need for advanced, innovative, and efficient treatment strategies for the better management of DFU. Many novel interventions, such as growth factor therapy, stem cell therapy, gene therapy, nanotechnology, bioengineered skin substitutes, 3D-bioprinting, and regenerative medicine, have shown promising roles in wound healing and tissue regeneration, suggesting their potential implications in the treatment and control of DFU. An integrated and multidisciplinary approach was proven to be a promising option for rapid and effective DFU management, eventually reducing the financial burden on the patients and healthcare system. Besides, AI-- driven medical technologies were found to support the healthcare system for the prevention, prediction, diagnosis, and personalized treatment of DFU. The present review article provides a brief overview of DFU and its pathophysiology. It highlights traditional DFU treatment strategies, their limitations, and focuses on emerging innovative strategies, emphasizing their potential for addressing DFU. Moreover, it sheds light on challenges and future research areas of these emerging interventions.</p>","PeriodicalId":10825,"journal":{"name":"Current diabetes reviews","volume":" ","pages":"e15733998407601"},"PeriodicalIF":2.6000,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current diabetes reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0115733998407601251010114114","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Diabetic Foot Ulcer (DFU) is a serious and chronic complication of uncontrolled diabetes, significantly increasing the risk of amputation and mortality in diabetic patients. Conventional wound healing techniques often fail to manage chronic wounds in DFU due to several limitations, which eventually raises the need for advanced, innovative, and efficient treatment strategies for the better management of DFU. Many novel interventions, such as growth factor therapy, stem cell therapy, gene therapy, nanotechnology, bioengineered skin substitutes, 3D-bioprinting, and regenerative medicine, have shown promising roles in wound healing and tissue regeneration, suggesting their potential implications in the treatment and control of DFU. An integrated and multidisciplinary approach was proven to be a promising option for rapid and effective DFU management, eventually reducing the financial burden on the patients and healthcare system. Besides, AI-- driven medical technologies were found to support the healthcare system for the prevention, prediction, diagnosis, and personalized treatment of DFU. The present review article provides a brief overview of DFU and its pathophysiology. It highlights traditional DFU treatment strategies, their limitations, and focuses on emerging innovative strategies, emphasizing their potential for addressing DFU. Moreover, it sheds light on challenges and future research areas of these emerging interventions.
期刊介绍:
Current Diabetes Reviews publishes frontier reviews on all the latest advances on diabetes and its related areas e.g. pharmacology, pathogenesis, complications, epidemiology, clinical care, and therapy. The journal"s aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all researchers and clinicians who are involved in the field of diabetes.